Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial-Reference-Cited by-同舟云学术

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Published:2015-02-25 Issue: Volume:16 Page:97-108
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Wright EJ¹²,Grund B³,Cysique LA⁴⁵,Robertson KR⁶,Brew BJ⁴⁵,Collins G⁷,Shlay JC⁸⁹,Winston A¹⁰,Read TRH¹¹¹²,Price RW¹³,

Affiliation:

1. Department of Infectious Diseases; Alfred Hospital and Monash University; Melbourne Victoria Australia

2. Burnet Institute; Melbourne Victoria Australia

3. School of Statistics; University of Minnesota; Minneapolis MN USA

4. University of New South Wales; Sydney New South Wales Australia

5. Peter Duncan Neurosciences Unit St Vincent's Centre for Applied Medical Research, St Vincent's Hospital; Sydney New South Wales Australia

6. AIDS Neurological Center, Neurology; University of North Carolina; Chapel Hill NC USA

7. Division of Biostatistics; University of Minnesota; Minneapolis MN USA

8. Department of Family Medicine; University of Colorado School of Medicine; Denver CO USA

9. Denver Public Health; Denver Health and Hospital Authority; Denver CO USA

10. Division of Medicine; Imperial College London; London UK

11. Victorian Infectious Diseases Service; Royal Melbourne Hospital; Melbourne Victoria Australia

12. Melbourne Sexual Health Centre; Alfred Health; Melbourne Victoria Australia

13. Department of Neurology; University of San Francisco California; San Francisco CA USA

Funder

National Institute of Neurological Disorders and Stroke

National Institute of Mental Health

National Health and Medical Research Council

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference36 articles.

1. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy;Bhaskaran;Ann Neurol,2008

2. Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS Cohort Study (MACS);Satz;J Acquir Immune Defic Syndr,1993

3. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons;Wright;Neurology,2010

4. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy;Childs;Neurology,1999

5. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients;Cysique;Neurology,2006

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep analysis of CD4 T cells in the rhesus CNS during SIV infection;PLOS Pathogens;2023-12-07

2. Prediction of incidence of neurological disorders in HIV-infected persons in Taiwan: a nested case–control study;BMC Infectious Diseases;2023-11-04

3. CD4 T cell Responses in the CNS during SIV infection;2023-08-25

4. Prediction of neurological disorders in HIV-infected persons in Taiwan: a nested case-control study;2023-08-05

5. One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV;HIV Medicine;2023-03-08